Cytarabine

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20068 publications

A DPHV-liver module recapitulates AML infiltration and chemotherapy-induced hepatotoxicity with translational utility.

A DPHV-liver module recapitulates AML infiltration and chemotherapy-induced hepatotoxicity with translational utility.

Journal: Science advances
Published: June 12, 2026

Composite CLL/SLL and Lymphoplasmacytic Lymphoma with IgM Anti-MAG Neuropathy: Clinicopathologic and Molecular Characterization of a Diagnostically Challenging Case.

Composite CLL/SLL and Lymphoplasmacytic Lymphoma with IgM Anti-MAG Neuropathy: Clinicopathologic and Molecular Characterization of a Diagnostically Challenging Case.

Journal: Annals of clinical and laboratory science
Published: June 08, 2026

Preventive Effect of Saline Eye Wash for Eye Symptoms Due to High-Dose and Intermediate-Dose Cytarabine Therapy

Preventive Effect of Saline Eye Wash for Eye Symptoms Due to High-Dose and Intermediate-Dose Cytarabine Therapy

Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: June 04, 2026

Efficacy and Safety of Venetoclax-Based Chemotherapy Regimens for High-Risk Acute Myeloid Leukemia

Efficacy and Safety of Venetoclax-Based Chemotherapy Regimens for High-Risk Acute Myeloid Leukemia

Journal: Zhongguo shi yan xue ye xue za zhi
Published: June 02, 2026

Analysis of the efficacy of half-dose venetoclax combined with reduced-dose HA regimen in the induction therapy of acute myeloid leukemia

Analysis of the efficacy of half-dose venetoclax combined with reduced-dose HA regimen in the induction therapy of acute myeloid leukemia

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: May 20, 2026

Cytarabine as a salvage mobilization strategy after failure of cyclophosphamide-based stem cell collection for Daratumumab-treated multiple myeloma patients.

Cytarabine as a salvage mobilization strategy after failure of cyclophosphamide-based stem cell collection for Daratumumab-treated multiple myeloma patients.

Journal: Leukemia & lymphoma
Published: May 08, 2026

Modern Management of Mantle Cell Lymphoma.

Modern Management of Mantle Cell Lymphoma.

Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: May 07, 2026

Behind the bleeding: rare and relentless uterine lymphoma ending in chemotherapy toxicity.

Behind the bleeding: rare and relentless uterine lymphoma ending in chemotherapy toxicity.

Journal: BMJ case reports
Published: May 04, 2026

Ten-day venetoclax plus fluconazole with azacitidine or low-dose cytarabine for elderly/unfit AML patients in resource-limited settings.

Ten-day venetoclax plus fluconazole with azacitidine or low-dose cytarabine for elderly/unfit AML patients in resource-limited settings.

Journal: Leukemia & lymphoma
Published: May 04, 2026

Primary Cutaneous Anaplastic Large Cell Lymphoma Mimicking Pyoderma Gangrenosum: An Atypical Presentation and Diagnostic Challenge.

Primary Cutaneous Anaplastic Large Cell Lymphoma Mimicking Pyoderma Gangrenosum: An Atypical Presentation and Diagnostic Challenge.

Journal: Cureus
Published: April 30, 2026

Higher Cumulative Cytarabine Consolidation Improves Survival in Older Adults with Acute Myeloid Leukemia.

Higher Cumulative Cytarabine Consolidation Improves Survival in Older Adults with Acute Myeloid Leukemia.

Journal: Cancers
Published: April 28, 2026

Frailty and Fitness in Older Adults With Acute Myeloid Leukemia: From Chronological Age to Multiparametric Assessment.

Frailty and Fitness in Older Adults With Acute Myeloid Leukemia: From Chronological Age to Multiparametric Assessment.

Journal: European journal of haematology
Published: April 22, 2026
Showing 1-12 of 20,068

Last Updated: 06/30/2026